نتایج جستجو برای: medulloblastoma

تعداد نتایج: 5231  

Journal: :Cancer research 2013
Joanna Triscott Cathy Lee Colleen Foster Branavan Manoranjan Mary Rose Pambid Rachel Berns Abbas Fotovati Chitra Venugopal Katrina O'Halloran Aru Narendran Cynthia Hawkins Vijay Ramaswamy Eric Bouffet Michael D Taylor Ash Singhal Juliette Hukin Rod Rassekh Stephen Yip Paul Northcott Sheila K Singh Christopher Dunham Sandra E Dunn

Medulloblastoma is the most common malignant brain tumor in children. This disease is heterogeneous and is composed of four subtypes of medulloblastoma [WNT, Sonic Hedgehog (SHH), Group 3, and Group 4]. An immediate goal is to identify novel molecular targets for the most aggressive forms of medulloblastoma. Polo-like kinase 1 (PLK1) is an oncogenic kinase that controls cell cycle and prolifera...

2017
Aline Gottlieb Kristina Althoff Laura Grunewald Theresa Thor Andrea Odersky Marc Schulte Hedwig E. Deubzer Lukas Heukamp Angelika Eggert Alexander Schramm Johannes H. Schulte Annette Künkele

Current therapy of medulloblastoma, the most common malignant brain tumor of childhood, achieves 40-70% survival. Secondary chemotherapy resistance contributes to treatment failure, where TP53 pathway dysfunction plays a key role. MDM2 interaction with TP53 leads to its degradation. Reactivating TP53 functionality using small-molecule inhibitors, such as RITA, to disrupt TP53-MDM2 binding may h...

Journal: :Neuro-oncology 2013
Joachim Silber Rintaro Hashizume Tristan Felix Sujatmi Hariono Mamie Yu Mitchel S Berger Jason T Huse Scott R VandenBerg C David James J Graeme Hodgson Nalin Gupta

Medulloblastoma is the most common malignant brain tumor in children, and a substantial number of patients die as a result of tumor progression. Overexpression of CDK6 is present in approximately one-third of medulloblastomas and is an independent poor prognostic marker for this disease. MicroRNA (miR)-124 inhibits expression of CDK6 and prevents proliferation of glioblastoma and medulloblastom...

Journal: :Cancer research 2005
Annie Huang Cynthia S W Ho Romina Ponzielli Dalia Barsyte-Lovejoy Eric Bouffet Daniel Picard Cynthia E Hawkins Linda Z Penn

c-myc oncogene activation is critical in the pathogenesis of a spectrum of human malignancies. The c-Myc NH2-terminal domain (MycNTD) is essential for cellular transformation, and mediates critical protein interactions that modulate c-Myc oncogenic properties. In medulloblastoma, the most common malignant pediatric brain tumor, deregulated c-myc expression is linked with poorer disease phenotyp...

2012
Joanna Keating Maria Tsoli Andrew R. Hallahan Wendy J. Ingram Michelle Haber David S. Ziegler

Medulloblastoma is the most common malignant brain tumor of childhood. Novel therapeutic strategies are urgently needed to overcome cytotoxic resistance. We hypothesized that antiapoptotic signals contribute to resistance and that treatment with proapoptotic agents could increase the efficacy of conventional therapies. A PCR array was used to assess the status of the apoptotic signaling pathway...

2015
Roberto Jose Diaz Brian Golbourn Claudia Faria Daniel Picard David Shih Denis Raynaud Michael Leadly Danielle MacKenzie Melissa Bryant Matthew Bebenek Christian A. Smith Michael D. Taylor Annie Huang James T. Rutka

Medulloblastoma comprises four molecular subgroups of which Group 3 medulloblastoma is characterized by MYC amplification and MYC overexpression. Lymphoma cells expressing high levels of MYC are susceptible to apoptosis following treatment with inhibitors of mitosis. One of the key regulatory kinases involved in multiple stages of mitosis is Aurora kinase B. We hypothesized that medulloblastoma...

2016
Kelsey Lynnea Whittier Daniel Bonthius Timothy Tewson Joshua Weiner Thomas Berger

Genome-wide association studies have identified several subgroups of medulloblastoma; however, few druggable targets have emerged. G-protein coupled receptors (GPCRs) possess characteristics that make them ideal targets for molecular imaging and therapeutics; drugs targeting GPCRs account for 30-40% of all current pharmaceuticals. While expression patterns of many proteins in human medulloblast...

2015
Bugra Kaya Pelin Ozcan Mustafa Karaagac Necmettin Erbakan Pelin Ozcan Kara

FDG PET/CT as a molecular imaging modality detected spinal cord metastases in a patient with medulloblastoma. Increased FDG uptake was reported as negatively correlated with survival in medulloblastoma in the literature. Although, spinal cord metastases associated with medulloblastoma detected with FDG-PET/CT imaging is a rare condition. To the best of our knowledge, this is the first report on...

Journal: :AJNR. American journal of neuroradiology 2000
T Stavrou E C Dubovsky G H Reaman A M Goldstein G Vezina

BACKGROUND AND PURPOSE Medulloblastoma is one of the most common posterior fossa tumors to occur in children. Our purpose was to document the frequency, location, and time of occurrence of intracranial calcifications in cranial CT studies of children with medulloblastoma. METHODS We retrospectively reviewed cranial CT studies of 56 patients diagnosed with medulloblastoma from 1983 through 199...

Journal: :acta medica iranica 0
haddad p behruzi h dehshiri k zarpak b

craniospinal irradiation plus posterior fossa boost (cs1) is the standard modality of post-operative treatment of patient with medulloblastoma, but considering the technical difficulties and limited facilities, often whole- brain irradiation plus posterior fossa boost (wbi) had been used in our institution until 1991. tust a retrospective study was undertaken to compare the patients treated by ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید